On March 5, 2018 Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, reported that financial results for the Fourth Quarter / Full Year 2017 and provide a general business update before the open of the U.S. markets on Thursday March 15, 2018 (Press release, Adaptimmune, MAR 5, 2018, View Source;p=RssLanding&cat=news&id=2336219 [SID1234524376]). Following the announcement, the company will host a live teleconference and webcast at 8:00 a.m. EDT (12:00 p.m. GMT) on the same day at which time management will provide a business update and discuss the financial results.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The press release and the live webcast of the conference call will be available in the investor section of Adaptimmune’s corporate website at www.adaptimmune.com. An archive will be available after the call at the same address.

To participate in the live conference call, if preferred, please dial 1-800-239-9838 (U.S.) or 44(0)330 336 9411 or 0800 279 7204 (United Kingdom). After placing the call, please ask to be joined into the Adaptimmune conference call and provide the confirmation code (5199507).

On March 5, 2018 Syros Pharmaceuticals (NASDAQ:SYRS), a biopharmaceutical company pioneering the development of medicines to control the expression of genes, reported that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at upcoming investor conferences (Press release, Syros Pharmaceuticals, MAR 5, 2018, View Source [SID1234524370]). Details are as follows:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

(Cowen and Company 38th Annual Health Care Conference
Date: Monday, March 12
Time: 12:00 p.m. ET
Location: The Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA

Oppenheimer 28th Annual Healthcare Conference
Date: Wednesday, March 21
Presentation Time: 2:10 p.m. ET
Location: The Westin New York Grand Central, 212 East 42nd Street, New York, NY

A live webcast of each presentation will be available on the Investors & Media section of the Syros website at www.syros.com. An archived replay of the webcast will be available for approximately 30 days following each presentation.

On March 5, 2018 pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President and Chief Executive Officer, is scheduled to present an overview of the Company and its progress at the 30th Annual ROTH Conference on Monday, March 12, 2018, at 5:00 p.m. ET (Press release, pSivida, MAR 5, 2018, View Source [SID1234524369]). The conference will be held at the Ritz Carlton, Laguna Nigel in Orange County, CA.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live audio and/or webcast and subsequent archived replay of pSivida’s presentation may be accessed via the Investors section of the Company’s website under "Resources – Events & Presentations" at www.psivida.com. The replay will be available for 90 days after the event.

On March 5, 2018 Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, reported that Chip Clark, president and chief executive officer, will present a corporate overview at two upcoming investor conferences (Press release, Genocea Biosciences, MAR 5, 2018, View Source [SID1234524368]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

and Company 38th Annual Health Care Conference
Monday, March 12, 2018Cowen at 11:20 AM ET in Boston, Massachusetts
Needham & Co. Annual Healthcare Conference
Tuesday, March 27, 2018 at 10:30 AM ET in New York, New York

A live webcast of both presentations can be accessed by visiting the "Events and Presentations" tab of the investor relations section of the Genocea website at View Source A replay of the webcasts will be archived for 30 days following the conference.

On March 5, 2018 BeiGene, Ltd. (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer, reported that the company will present at two upcoming investor conferences (Press release, BeiGene, MAR 5, 2018, View Sourcephoenix.zhtml?c=254246&" target="_blank" title="View Sourcephoenix.zhtml?c=254246&" rel="nofollow">View Source;p=RssLanding&cat=news&id=2336089 [SID1234524365])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The Cowen and Company 38th Annual Health Care Conference in Boston on Monday, March 12, at 2:10 p.m. (ET); and
The Barclays Global Healthcare Conference 2018 in Miami on Wednesday, March 14, at 4:20 p.m. (ET).
Live webcasts can be accessed from the investors section of BeiGene’s website at View Source and archived replays will be available for 90 days following each event.